• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在学术医疗中心将生物医学发现优化为文化变革的引擎。

Optimizing biomedical discoveries as an engine of culture change in an academic medical center.

作者信息

DeChant Anne K, Fening Stephen, Haag Michael, Harte William, Chance Mark R

机构信息

Office of Translation and Innovation, Clinical and Translational Science Collaborative, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.

出版信息

J Clin Transl Sci. 2022 Jan 2;6(1):e19. doi: 10.1017/cts.2021.888. eCollection 2022.

DOI:10.1017/cts.2021.888
PMID:35291218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8889224/
Abstract

Academic discovery in biomedicine is a growing enterprise with tens of billions of dollars in research funding available to universities and hospitals. Protecting and optimizing the resultant intellectual property is required in order for the discoveries to have an impact on society. To achieve that, institutions must create a multidisciplinary, collaborative system of review and support, and utilize connections to industry partners. In this study, we outline the efforts of Case Western Reserve University, coordinated through its Clinical and Translational Science Collaborative (CTSC), to promote entrepreneurial culture, and achieve goals of product development and startup formation for biomedical and population health discoveries arising from the academic ecosystem in Cleveland. The CTSC Office of Translation and Innovation, with the university's Technology Transfer Office (TTO), helps identify and derisk promising IP while building interdisciplinary project teams to optimize the assets through key preclinical derisking steps. The benefits of coordinating funding across multiple programs, assuring dedicated project management to oversee optimizing the IP, and ensuring training to help improve proposals and encourage an entrepreneurial culture, are discussed in the context of a case study of therapeutic assets, the Council to Advance Human Health. This case study highlights best practices in academic innovation.

摘要

生物医学领域的学术发现是一个不断发展的事业,大学和医院可获得数百亿美元的研究资金。为了使这些发现对社会产生影响,需要保护并优化由此产生的知识产权。要做到这一点,各机构必须创建一个多学科、协作性的审查与支持系统,并利用与行业合作伙伴的联系。在本研究中,我们概述了凯斯西储大学通过其临床与转化科学协作中心(CTSC)所做的努力,以促进创业文化,并实现产品开发目标以及为克利夫兰学术生态系统中产生的生物医学和人群健康发现创建初创企业。CTSC的翻译与创新办公室与大学的技术转让办公室(TTO)合作,在组建跨学科项目团队以通过关键的临床前风险降低步骤优化资产的同时,帮助识别有前景的知识产权并降低其风险。在治疗性资产“促进人类健康理事会”的案例研究背景下,讨论了跨多个项目协调资金、确保有专门的项目管理来监督知识产权优化以及确保提供培训以帮助改进提案并鼓励创业文化的益处。本案例研究突出了学术创新的最佳实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/8889224/41dc392b989a/S2059866121008888_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/8889224/caf00e7cae83/S2059866121008888_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/8889224/41dc392b989a/S2059866121008888_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/8889224/caf00e7cae83/S2059866121008888_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0588/8889224/41dc392b989a/S2059866121008888_fig2.jpg

相似文献

1
Optimizing biomedical discoveries as an engine of culture change in an academic medical center.在学术医疗中心将生物医学发现优化为文化变革的引擎。
J Clin Transl Sci. 2022 Jan 2;6(1):e19. doi: 10.1017/cts.2021.888. eCollection 2022.
2
A roadmap for research in medical physics via academic medical centers: The DIVERT Model.通过学术医疗中心进行医学物理研究的路线图:DIVERT 模型。
Med Phys. 2021 Jun;48(6):3151-3159. doi: 10.1002/mp.14849. Epub 2021 Apr 7.
3
Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?健康研究与创新:能否优化初创企业/制药公司与医疗机构之间的界面?
Therapie. 2020 Jan-Feb;75(1):113-123. doi: 10.1016/j.therap.2019.11.010. Epub 2019 Dec 14.
4
Fostering innovation at Academic Medical Centers: The Case of University of Colorado Anschutz Medical Campus.促进学术医疗中心的创新:以科罗拉多大学安舒茨医学校区为例。
J Clin Transl Sci. 2021 May 17;5(1):e148. doi: 10.1017/cts.2021.792. eCollection 2021.
5
Science-based health innovation in Uganda: creative strategies for applying research to development.乌干达基于科学的健康创新:将研究应用于发展的创造性策略。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S5. doi: 10.1186/1472-698X-10-S1-S5.
6
[Thoughts of the combination of medicine and engineering and collaborative innovation on surgery in China].[关于中国医学与工程学结合及外科领域协同创新的思考]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jun 25;23(6):562-565. doi: 10.3760/cma.j.cn.441530-20200331-00174.
7
Collaborative academic medical product development: An 8-year review of commercialization outcomes at the Institute of Translational Health Sciences.合作性学术医疗产品开发:对转化健康科学研究所商业化成果的8年回顾
J Clin Transl Sci. 2017 Aug;1(4):229-234. doi: 10.1017/cts.2017.13. Epub 2017 Aug 15.
8
Academic medical product development: an emerging alliance of technology transfer organizations and the CTSA.学术性医疗产品开发:技术转移组织与临床与转化科学奖联盟的新兴合作关系
Clin Transl Sci. 2014 Dec;7(6):456-64. doi: 10.1111/cts.12175. Epub 2014 Jun 19.
9
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者:来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
10
Technology Transfer: From the Research Bench to Commercialization: Part 2: The Commercialization Process.技术转移:从研究台到商业化:第二部分:商业化过程
JACC Basic Transl Sci. 2017 Apr 24;2(2):197-208. doi: 10.1016/j.jacbts.2017.03.004. eCollection 2017 Apr.

引用本文的文献

1
Competency gaps and institutional challenges for translational research in medical devices: insights from Brazilian researchers.医疗器械转化研究中的能力差距与机构挑战:来自巴西研究人员的见解
BMC Med Educ. 2025 Apr 18;25(1):571. doi: 10.1186/s12909-025-07160-4.
2
Training T-shaped translational scientists.培养T型转化科学家。
J Clin Transl Sci. 2024 Dec 16;9(1):e5. doi: 10.1017/cts.2024.674. eCollection 2025.
3
Military Medicine and Medical Research as a Source of Inspiration and Innovation to Solve National Security and Health Challenges in the 21st Century.

本文引用的文献

1
New programs for translating research to patient care: Lessons learned at the NIH Center for Accelerated Innovations at Cleveland Clinic.将研究成果转化为患者护理的新计划:在美国国立卫生研究院克利夫兰诊所加速创新中心获得的经验教训。
J Clin Transl Sci. 2021 Sep 13;5(1):e176. doi: 10.1017/cts.2021.849. eCollection 2021.
2
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D.基准化生物制药工艺开发和制造对研发的成本贡献。
MAbs. 2020 Jan-Dec;12(1):1754999. doi: 10.1080/19420862.2020.1754999.
3
Innovation in the pharmaceutical industry: New estimates of R&D costs.
军事医学与医学研究:作为解决21世纪国家安全与健康挑战的灵感与创新源泉
Pathog Immun. 2023 Sep 8;8(1):51-63. doi: 10.20411/pai.v8i1.596. eCollection 2023.
4
Translational research in health technologies: A scoping review.卫生技术领域的转化研究:一项范围综述。
Front Digit Health. 2022 Aug 3;4:957367. doi: 10.3389/fdgth.2022.957367. eCollection 2022.
5
Training the next generation of translational scientists: The Case Western Reserve University Translational Fellows Program.培养下一代转化医学科学家:凯斯西储大学转化医学研究员项目
J Clin Transl Sci. 2022 Apr 19;6(1):e47. doi: 10.1017/cts.2022.390. eCollection 2022.
制药行业的创新:研发成本的新估计
J Health Econ. 2016 May;47:20-33. doi: 10.1016/j.jhealeco.2016.01.012. Epub 2016 Feb 12.